Sean Fetcho

Sean Fetcho is the co-founder and CEO of Verséa Health, Inc., a global healthcare company committed to transforming scientific discoveries into applicable health and wellness solutions.

Sean’s shared passion for the evolving healthcare industry and for building early-stage companies prompted him to drive explosive growth for Verséa Health over the past few years.

Prior to Verséa Health, Sean’s roster of early stage and start-up companies includes multiple industries spanning from Agrotech, online consumer magazines and finance.

Sean successfully created, launched, and oversaw 8 highly successful print and digital publication that targeted oncology, pain management and cardiology professionals, all of which remain in circulation today. He was then recruited into a Continuing Medical Education (CME) company where Sean developed and executed on new revenue streams that helped structure the business for an exit. Within 3 years, Aventine (PAINWeek) sold to a publicly traded company on the London Stock Exchange.